These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16334945)

  • 1. Comparison of myocardial contrast enhancement via cardiac magnetic resonance imaging in healthy cats and cats with hypertrophic cardiomyopathy.
    MacDonald KA; Wisner ER; Larson RF; Klose T; Kass PH; Kittleson MD
    Am J Vet Res; 2005 Nov; 66(11):1891-4. PubMed ID: 16334945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.
    MacDonald KA; Kittleson MD; Larson RF; Kass P; Klose T; Wisner ER
    J Vet Intern Med; 2006; 20(5):1093-105. PubMed ID: 17063701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Doppler imaging and gradient echo cardiac magnetic resonance imaging in normal cats and cats with hypertrophic cardiomyopathy.
    MacDonald KA; Kittleson MD; Garcia-Nolen T; Larson RF; Wisner ER
    J Vet Intern Med; 2006; 20(3):627-34. PubMed ID: 16734100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy.
    MacDonald KA; Kittleson MD; Kass PH; White SD
    J Vet Intern Med; 2008; 22(2):335-41. PubMed ID: 18346145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of left ventricular mass using cardiac magnetic resonance imaging compared with echocardiography in domestic cats.
    MacDonald KA; Kittleson MD; Reed T; Larson R; Kass P; Wisner ER
    Vet Radiol Ultrasound; 2005; 46(3):192-9. PubMed ID: 16050275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy.
    Fries RC; Kadotani S; Keating SCJ; Stack JP
    J Vet Intern Med; 2021 Mar; 35(2):812-822. PubMed ID: 33634479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue Doppler imaging in Maine Coon cats with a mutation of myosin binding protein C with or without hypertrophy.
    MacDonald KA; Kittleson MD; Kass PH; Meurs KM
    J Vet Intern Med; 2007; 21(2):232-7. PubMed ID: 17427382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension.
    Carlos Sampedrano C; Chetboul V; Gouni V; Nicolle AP; Pouchelon JL; Tissier R
    J Vet Intern Med; 2006; 20(5):1106-15. PubMed ID: 17063702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: The effects of myocardial hypertrophy and fibrosis.
    Xu HY; Chen J; Yang ZG; Li R; Shi K; Zhang Q; Liu X; Xie LJ; Jiang L; Guo YK
    J Magn Reson Imaging; 2017 Nov; 46(5):1368-1376. PubMed ID: 28370909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart.
    Cardim N; Oliveira AG; Longo S; Ferreira T; Pereira A; Reis RP; Correia JM
    J Am Soc Echocardiogr; 2003 Mar; 16(3):223-32. PubMed ID: 12618730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic indicators in cats with hypertrophic cardiomyopathy.
    Payne JR; Borgeat K; Connolly DJ; Boswood A; Dennis S; Wagner T; Menaut P; Maerz I; Evans D; Simons VE; Brodbelt DC; Luis Fuentes V
    J Vet Intern Med; 2013; 27(6):1427-36. PubMed ID: 24134821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.